Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Neuroprotective Impact of Magnesium Sulphate Therapy for Preterm Deliveries. Loading Dose Alone Strategy Versus Loading Plus Maintenance Dose Strategy.

NCT05674565 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05674565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05674565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Neuroprotective Impact of Magnesium Sulphate Therapy for Preterm Deliveries. Loading Dose Alone Strategy Versus Loading Plus Maintenance Dose Strategy.
Lead sponsor
Zagazig University
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 20, 2023
Completion date
July 15, 2024
Enrollment
336 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, magnesium sulphate, neonatal death, neuroprotection, premature birth